Search - tctmd.com

Displaying 81 - 98 of 98

Sort: Relevancy | Date

Presentation TCT 2019

Atherectomy, Balloons, and Stents: Data Update

Presenter: Eric Secemsky

September 28, 2019

Presentation TCT 2019

Long-Term Safety of Drug-Coated Devices for Femoropopliteal Artery Revascularization: Updated Analysis of Medicare Beneficiary Data

Presenter: Eric Secemsky

September 27, 2019

Presentation TCT 2019

Drug-Coated Balloons in the Periphery: Red Alert or Red Herring?

Presenter: Eric Secemsky

September 27, 2019

News Daily News

Use of IVC Filters for DVT Peaked in 2010 but Remains High

Michael O'Riordan

August 28, 2019

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

L.A. McKeown

June 19, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

News Daily News

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Michael O'Riordan

January 15, 2019

Presentation TCT 2018

Complications of IVC Filters: Spectrum, Frequency, Treatment, and Avoidance Strategies

Presenter: Jay S. Giri, Akhilesh K. Sista, Eric A Secemsky

September 24, 2018

News Daily News

Burden of Readmission High in PAD Patients Following Revascularization

L.A. McKeown

December 04, 2017

News Daily News

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

L.A. McKeown

May 03, 2017

News Featured Fellow

Eric Secemsky, MD, MSc

Yael L. Maxwell

March 21, 2017

News Daily News

登记表数据显示原发性 PCI 患者比伐卢定与肝素使用率波动

Yael L. Maxwell

November 11, 2016

News Daily News

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

November 11, 2016

News Daily News

Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias

Yael L. Maxwell

November 11, 2016

News Daily News

Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge

Todd Neale

October 18, 2016

News Daily News

STEMI Patients Not Achieving Recommended Transfer Times for PCI

L.A. McKeown

December 05, 2011

Video

» On Record

On Record: The Paclitaxel PAD Controversy: Is It Over?

November 30, 2023

Advertisement

Atherectomy, Balloons, and Stents: Data Update

Long-Term Safety of Drug-Coated Devices for Femoropopliteal Artery Revascularization: Updated Analysis of Medicare Beneficiary Data

Drug-Coated Balloons in the Periphery: Red Alert or Red Herring?

Use of IVC Filters for DVT Peaked in 2010 but Remains High

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Complications of IVC Filters: Spectrum, Frequency, Treatment, and Avoidance Strategies

Burden of Readmission High in PAD Patients Following Revascularization

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

Eric Secemsky, MD, MSc

登记表数据显示原发性 PCI 患者比伐卢定与肝素使用率波动

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias

Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge

STEMI Patients Not Achieving Recommended Transfer Times for PCI

On Record: The Paclitaxel PAD Controversy: Is It Over?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content